PriceC.G., SukiW.N.Newer modifications of peritoneal dialysis: Options in the treatment of patients with renal failure.Am J Nephrol1981; 1(2): 97–104.
5.
McCombJ., MortonA.R., SingerM.A., HopmanW.M., MacKenzieT.Impact of portable APD on patient perception of health-related quality of life. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1997; 13: 137–40.
6.
United States Department of Health and Human Services.Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 1997 Annual Data Report [CD ROM version]. Bethesda: United States Renal Data System; 1997.
KeshaviahP., EmersonP.F., VoneshE.F., BrandesJ.C.Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis.J Am Soc Nephrol1994; 4(10): 1820–6.
11.
DurandP.Y., ChanliauJ., GambéroniJ., HestinD., KesslerM.APD: Clinical measurement of the maximal acceptable intraperitoneal volume. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1994; 10: 63–7.
FreidaP.H., IssadB., AllouacheM.Relationships between fill volume, small solute clearances, and net ultrafiltration during a standardized APD program [Abstract].Perit Dial Int1998; 18(1): 124.
25.
National Kidney Foundation Dialysis Outcomes Quality Initiative.Computer-assisted kinetic modelling approach to achieving target doses of peritoneal dialysis. Clinical practice guidelines for peritoneal dialysis adequacy.Am J Kidney Dis1997; 30(Suppl 2): S90–2.
26.
VoneshE.F., LysaghtM.J., MoranJ., FarrellP.Kinetic modelling as a prescription aid in peritoneal dialysis.Blood Purif1991; 9: 246–70.
27.
VoneshE.F., BurkartJ., McMurrayS.D., WilliamsP.F.Peritoneal dialysis kinetic modelling: Validation in a multicenter clinical study.Perit Dial Int1996; 16: 471–81.
28.
RippeB., StelinG., HaraldssonB.Computer simulations of peritoneal fluid transport in CAPD.Kidney Int1991; 40: 315–25.
29.
HaraldssonB.Assessing the peritoneal dialysis capacities of individual patients.Kidney Int1995; 47: 1187–98.
30.
GotchF.A., KeenM.L.Kinetic modelling in peritoneal dialysis. In: NissensonA.R., FineR.N., GentileD.E., eds. Clinical dialysis. Third edition.Norwalk, Connecticut: Appleton & Lange;1996: 343–75.
31.
GotchF.A., LippsB.J., KeenM.L., PanlilioF.Computerized urea kinetic modelling to prescribe and monitor delivered Kt/V (pKt/V, dKt/V) in peritoneal dialysis. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 43–5.
32.
AmiciG., MastrosimoneS., Da RinG., BocciC., BonadonnaA.Clinical validation of PD Adequest software: Modelling error assessment.Perit Dial Int1998; 18(3): 317–21.
33.
VerrinaE., AmiciG., PerfumoF., TrivelliA., CanepaA., GusmanoR.The use of the PD Adequest mathematical model in pediatric patients on chronic peritoneal dialysis.Perit Dial Int1998; 18(3): 322–8.
34.
KeshaviahP.R., NolphK.D., Van StoneJ.C.The peak urea concentration hypothesis: A urea kinetic approach to comparing the adequacy of CAPD and hemodialysis.Perit Dial Int1989; 9: 257–60.
35.
National Kidney Foundation Dialysis Outcomes Quality Initiative.Clinical practice guidelines for peritoneal dialysis adequacy. III. Measurement of peritoneal dialysis dose.Am J Kidney Dis1997; 30(Suppl 2): S80–2.
36.
National Kidney Foundation Dialysis Outcomes Quality Initiative.Clinical practice guidelines for peritoneal dialysis adequacy. V. Adequate dose of peritoneal dialysis.Am J Kidney Dis1997; 30(Suppl 2): S86–92.
37.
KeshaviahP.R., StarR.A.A new approach to dialysis quantification: An adequacy index based on solute removal.Semin Dial1994; 7: 85–90.
RoncoC., BoschJ.P., LewS.Q., FerianiM., ChiaramonteS., ConzP.Adequacy of continuous ambulatory peritoneal dialysis: Comparison with other dialysis techniques.Kidney Int1994; 46(Suppl 48): S18–24.
40.
AmiciG., CalzavaraP., Da RinG., BocciC., CalconiG.Solute removal index (SRI) and equivalent renal clearance (EKR) for dialysis dose quantification in CAPD, APD, and standard HD [Abstract].Perit Dial Int1998; 18(Suppl 1): S11.
41.
CanaudB., GarredL.J., ArgilesA., FlavierJ.L., BoulouxC., MionC.Creatinine kinetic modelling: A simple and reliable tool for the assessment of protein nutritional status in haemodialysis patients.Nephrol Dial Transplant1995; 10: 1405–10.
42.
AmiciG., VirgaG., Da RinG., BocciC.Kt/V target calculation in automated tidal PD treatment using solute removal index [Abstract].Perit Dial Int1998; 18(1): 101.
43.
ChenH.H., ShettyA., AfthentopoulosI.E., OreopoulosD.G.Discrepancy between weekly Kt/V and weekly creatinine clearances in patients on CAPD. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1995; 11: 83–7.
44.
TzamaloukasA.H., MurataG.H., PirainoB., RaoP., BernardiniJ., MalhotraD.Peritoneal urea and creatinine clearance in continuous peritoneal dialysis patients with different types of peritoneal solute transport.Kidney Int1998; 53: 1405–11.
45.
MehrotraR., SaranR., NolphK.D., MooreH.L., KhannaR.Evidence that urea is a better surrogate marker of uremic toxicity than creatinine.ASAIO J1997; 43(5): M858–61.
46.
AmiciG., MastrosimoneS., VirgaG., Da RinG., BocciC.Variability of adequacy indices derived from 24h collections in APD [Abstract].Perit Dial Int1998; 18(1): 101.
47.
RodbyR.A., FiranekC.A., ChengY.G., KorbetS.M.Reproducibility of studies of peritoneal dialysis adequacy.Kidney Int1996; 50(1): 267–71.
48.
ChurchillD.N., TaylorD.W., KeshaviahP.R., and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
49.
Diaz–BuxoJ.A.Enhancement of peritoneal dialysis: The PD Plus concept.Am J Kidney Dis1996; 27(1): 92–8.
50.
KorbetS.M., VoneshE.F., FiranekC.A.Peritonitis in an urban peritoneal dialysis program: An analysis of infecting pathogens.Am J Kidney Dis1995; 26(1): 47–53.
51.
Vande WalleJ., RaesA., CastilloD., Lutz–DettingerN., DejaegherA.Advantages of HCO3 solution with low sodium concentration over standard lactate solutions for acute peritoneal dialysis. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1997; 13: 179–82.
52.
StruijkD.G., DoumaC.E.Future research in peritoneal dialysis fluids.Semin Dial1998; 11(4): 207–12.
53.
CanepaA., PerfumoF., CarreaA., VerrinaE., MenoniS., TrivelliA.Long-term effects of amino acid solutions in children on automated peritoneal dialysis [Abstract].J Am Soc Nephrol1996; 7(9): 1441.
54.
LeblancM., MorenoL., RobinsonO., TapolyaiM., PaganiniE.P.Bicarbonate dialysate for continuous renal replacement therapy [Abstract].J Am Soc Nephrol1995; 6(3): 497.
55.
AshS.R., JanleE.M.Continuous flow-through peritoneal dialysis (CFPD): Comparison of efficiency to IPD, TPD, and CAPD in an animal model.Perit Dial Int1997; 17(4): 365–72.
56.
SteeleM., KwanJ.T.Potential problem: Delayed detection of peritonitis by patients receiving home automated peritoneal dialysis.Perit Dial Int1997; 17(6): 617–22.
57.
RoncoC., BrendolanA., ZanellaM.Evolution of machines for automated peritoneal dialysis.Contrib Nephrol1999; 129: 142–61.